This study was aimed at defining the therapeutic value of percutaneous ethanol injection in patients with solitary hepatocellular carcinoma less than 4 cm. Ultrasound-guided ethanol injection was performed in 24 cirrhotic patients (9 Child A, 10 Child B and 5 Child C), with hepatocellular carcinoma
Percutaneous ethanol treatment of hepatocellular carcinoma (HCC): large volumes for large tumors
✍ Scribed by Christophe Bastid; Camille Azar; José Sahel
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 270 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0929-8266
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## BACKGROUND. The objective of this study was to evaluate the indications for percutaneous ethanol injection (PEI) performed in a single session under general anesthesia for treating patients with cirrhosis and large (tumors Ͼ 5 cm) hepatocellular carcinoma (HCC), and relevant survival curves. #
## Background: The long term efficacy of combination therapy with transcatheter arterial embolization (tae) followed by percutaneous ethanol injection (pei) was studied in patients with large primary hepatocellular carcinoma (hcc) tumors and cirrhosis. ## Methods: The series included 83 patients
The currently available indication criteria of living donor liver transplantation (LDLT) for patients with hepatocellular carcinoma (HCC) have high prognostic power but insufficient discriminatory power. On the basis of single-center results from 221 HCC patients undergoing LDLT, we modified the ind